PRVL News and Press, Prevail Therapeutics Inc.

Gain’s cutting-edge precision medicine platform and novel compounds enable therapeutic access to previously undruggable targets. Public investors can access this disruptive technology at a venture-like valuation. A clean balance sheet funds the business until H2 2023, with ...

Gain Therapeutics has filed to raise $40 million in a U.S. IPO. The firm is a preclinical biopharma developing treatments for lysosomal storage disorders. GANX has a number of research collaborations, but is still at a very early stage of development, so maybe more relevant for in...

Eli Lilly and Company shares rise ([[LLY]] +2.4%) on the back of the drugmaker's completion of its acquisition of Prevail Therapeutics ([[PRVL]]) enabling the creation of a gene therapy program that will be anchored by Prevail's portfolio of clinical-stage and preclinical neuroscience as...

Prevail getting bought by Eli Lilly for $22.50 plus a potential $4.00 in CVR payments. The payment terms are straightforward and the timeline is long here, which improves the chances of the CVR paying out. Structural forces in the market often result in CVRs being underpriced. ...

Merger activity decreased last week with six new deals announced. Acacia Communications and Cisco Systems announced an amendment to their merger agreement. Google completes the acquisition of Fitbit. For further details see: Merger Arbitrage Mondays - Fitbit Closes And A...

2020 was a year of immense adversity and contrast, as stocks bounced back sharply from a pandemic-induced bear market. Biotechs play a pivotal role in managing down the pandemic as vaccine production ramps higher. January to provide further insights on multiple additional vaccine tria...

Merger activity increased significantly last week with eight new deals announced. The acquisition of Alaska Communications Systems Group by ATN International. The acquisition of FLIR Systems by Teledyne Technologies Incorporated. For further details see: Merger...

NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Altimar Acquisition Corp. (NYSE: ATAC ) relat...

The iShares Nasdaq Biotechnology ETF includes both COVID-19 and other plays. The ETF is up by 26% during the last year and there are questions around further growth. While some analysts have a neutral stance, there are some indications which point to more upside, despite uncertain...

NEW YORK, NY / ACCESSWIRE / January 5, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: RealPage, Inc. (NASDAQ:RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties rel...